Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
BioLineRx Ltd
YP2ACurrent price
0.33 EUR
-0.014 EUR (-4.12%)
Last closed
0.41 USD
Company
www.biolinerx.com
ISIN
US09071M2052
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
41 363 056 USD
Yield for 12 month
-72.69 %
1Y
3Y
5Y
10Y
15Y
YP2A
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel. Address: Modi?in Technology Park, Hevel Modi'in, Israel, 7177871
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.83 USDP/E ratio
–Dividend Yield
–Current Year
+4 800 000 USD
Last Year
–
Current Quarter
+5 393 000 USD
Last Quarter
+6 855 000 USD
Current Year
+174 000 USD
Last Year
-654 000 USD
Current Quarter
+4 251 000 USD
Last Quarter
+5 400 000 USD
Key Figures YP2A
1 year
3 years
5 years
10 years
EBITDA
-33 080 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.23 %
PEG Ratio
0.2
Return On Equity TTM
-171.94 %
Wall Street Target Price
9.83 USD
Revenue TTM
17 048 000 USD
Book Value
0.012 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.45 USD
Diluted Eps TTM
-0.45 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-176.67 %
Dividend Analytics YP2A
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History YP2A
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
15.07.2019
Dividend Date
15.07.2019
Stock Valuation YP2A
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.8986
Price Sales TTM
2.4263
Enterprise Value EBITDA
-0.6709
Price Book MRQ
2.3158
Financials YP2A
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators YP2A
For 52 weeks
0.39 USD
1.93 USD
50 Day MA
0.58 USD
Shares Short Prior Month
137 659
200 Day MA
0.81 USD
Short Ratio
1.94
Shares Short
621 386
Short Percent
0.78 %
BeatStart